Abstract:Fan Zhang, 1– 3 Wenjian Li 1, 4 1 Changzhou Clinical College, Xuzhou Medical University, Changzhou, Jiangsu, People's Republic of China; 2 Department of Endocrinology, Changzhou Third People's Hospital, Changzhou, Jiangsu, People's Republic of China; 3 Department of Clinical Nutrition, Changzhou Third People's Hospital, Changzhou, Jiangsu, People's Republic of China; 4 Department of Urology, Changzhou Third People's Hospital, Changzhou, Jiangsu, People's Republic of China Correspondence: Wenjian Li, Department of Urology, Changzhou Third People's Hospital, 300 Lanling North Road, Changzhou, Jiangsu, 213001, People's Republic of China, Tel +86-0519-82009011, Email Objective: This study examined the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and urinary incontinence in adult women and evaluated the potential contribution of the fatty liver index (FLI) in this context. Methods: The study utilized data from the National Health and Nutrition Examination Survey (NHANES) database, spanning from 2001 to 2018. The study included 17,221 adult female participants. Individuals exhibiting FLI values of 60 or greater were diagnosed with hepatic steatosis. Incontinence type and MASLD status were evaluated by analyzing questionnaire data and calculating the FLI. Logistic regression models were employed to examine the correlation between FLI, MASLD, and urinary incontinence, with potential confounding variables controlled through multivariate adjustment models. Furthermore, restricted cubic spline curve (RCS) modeling and subgroup analysis were employed to elucidate the relationship between variables further. Results: The median age of participants in the MASLD group was higher than that of the non-MASLD group (53 vs 46 years, P < 0.001). The findings indicated a positive association between FLI and MASLD and the risk of urinary incontinence. Specifically, the risk of stress urinary incontinence (SUI), urgency urinary incontinence (UUI), and mixed urinary incontinence (MUI) all increased significantly with increasing quartiles of FLI (OR 2.44, 1.91, 2.30, respectively, P < 0.001). In the multivariate-adjusted model, SUI, UUI, and MUI risk was 76%, 50%, and 69% higher in patients with MASLD than those without MASLD. RCS analysis demonstrated a significant nonlinear positive correlation between FLI and the risk of SUI, UUI, and MUI, respectively. Conclusion: This study's findings indicate a significant association between MASLD and the risk of developing urinary incontinence. Additionally, the results suggest that FLI and MASLD may act as independent risk factors for urinary incontinence. Keywords: metabolic dysfunction-associated steatotic liver disease, urinary incontinence, fatty liver index, adult women, correlation study Metabolic dysfunction-associated steatosis liver disease (MASLD) is a chronic liver disease with a solid correlation to obesity, insulin resistance, and metabolic syndrome. 1 In recent years, with the prevalence of obesity and metabolic syndrome on a global scale, the incidence of MASLD has risen dramatically, becoming a significant challenge in international public health. 2,3 MASLD is characterized by the abnormal accumulation of fat in the liver and is often accompanied by systemic metabolic abnormalities, including insulin resistance, dyslipidemia, and systemic inflammation. These pathological processes significantly increase the risk of complications, including cardiovascular disease, diabetes, and chronic kidney disease. 1,4,5 Urinary incontinence is a prevalent urological disorder among adult women, significantly impacting their quality of life and social participation. 6,7 The pathogenesis of this condition is complex, involving multiple aspects of pelvic floor muscle function, nervous system regulation, and hormone levels. 8,9 In particular, the age-related decline in muscle mass, strength, and function is typical among older women. These physiological changes are frequently accompanied by sarcopenia, which significantly elevates the risk of urinary incontinence. 10,11 Although MASLD and urinary incontinence are often considered distinct entities in clinical practice, there is mounting evidence that they may be associated. 12 MASLD primarily affects the liver, yet its metabolic disorders and systemic inflammation may impact urinary function via many mechanisms, including neuroendocrine, vascular, or immune, which may elevate the risk of urinary disorders such as urinary incontinence. The relationship between MASLD and urinary incontinence is currently understudied, and the evidence needs to be more conclusive. It is, theref -Abstract Truncated-

Correlation Between Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Urinary Incontinence in Adult Women